Citation Impact
Citing Papers
Diabetes and Cardiovascular Disease
1999 Standout
The metabolic syndrome in children and adolescents ? an IDF consensus report
2007 Standout
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Systematic review of the health benefits of physical activity and fitness in school-aged children and youth
2010 Standout
Physician Gender and Hormone Replacement Therapy Discussion
2001
Evaluation and management of hypo-osmolality in hospitalized patients
2003
Thiazolidinediones
2004 Standout
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Clinical Significance, Pathogenesis, and Management of Postprandial Hyperglycemia
2003
Familial components of the multiple metabolic syndrome: the ARIC Study
1997
Managing Type 2 Diabetes: Balancing HbA1cand Body Weight
2010
Oral antidiabetic agents: 2004
2004
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
The metabolic syndrome: is this diagnosis necessary?1,2
2006
The metabolic syndrome
2010 Standout
Initial Management of Glycemia in Type 2 Diabetes Mellitus
2002
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
2017 Standout
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome—an analysis by structural equation modelling
2002
Oral Antihyperglycemic Therapy for Type 2 Diabetes
2002
The mechanisms of action of metformin
2017 Standout
Oxidative DNA damage and obesity in type 2 diabetes mellitus
2011
Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity
2002
Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
2009 Standout
Insulin action in vascular endothelium: potential mechanisms linking insulin resistance with hypertension
2000
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
2010
Obesity
2005 Standout
Impact of sleep debt on metabolic and endocrine function
1999 Standout
Randomized Placebo‐Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM‐DM Study
2012 Standout
The metabolic syndrome
2005 Standout
The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals
2004
Clinical practice guideline on diagnosis and treatment of hyponatraemia
2014 Standout
Autonomic imbalance, hypertension, and cardiovascular risk
2000
Type 2 diabetes
2017 Standout
The insulin resistance syndrome
2003
Metformin hydrochloride in the treatment of type 2 diabetes mellitus: A clinical review with a focus on dual therapy
2003
Equine Metabolic Syndrome
2010 Standout
Pharmacology of the Meglitinide Analogs
2003
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Insulin and insulin resistance:
2004 Standout
The role of vagal function in the risk for cardiovascular disease and mortality
2006 Standout
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
2006 Standout
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
2010
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
Meglitinide analogues: a review of clinical data focused on recent trials
2006
Hypertension and Associated Metabolic Abnormalities — The Role of Insulin Resistance and the Sympathoadrenal System
1996
Physician Gender Effects in Medical Communication
2002 Standout
Conflict of Interest in the Debate over Calcium-Channel Antagonists
1998 Standout
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
2013 Standout
Obesity and the Metabolic Syndrome in Children and Adolescents
2004 Standout
Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes
2017
Relationship between obesity, insulin resistance, and coronary heart disease risk
2002
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat
1997
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Definition of Metabolic Syndrome
2004 Standout
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2008 Standout
Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction
2006 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Fasting and Postchallenge Glycemia and Cardiovascular Disease Risk
2002
Treatment of Patients Over 64 Years of Age With Type 2 Diabetes
2003
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
2001 Standout
Treatment of Childhood Syndrome X
1997
Prevention and Treatment of the Metabolic Syndrome
2004
Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus
2004 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Insulin Resistance/Compensatory Hyperinsulinemia, Essential Hypertension, and Cardiovascular Disease
2003
Dose-Response Effect of Pioglitazone on Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes
2002
Plasma Fibrinogen: A New Factor of the Metabolic Syndrome: A population-based study
1998
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
2002 Standout
Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans
2000 Standout
Meglitinide analogues for type 2 diabetes mellitus
2007
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Andrographis paniculata(Burm. f.) Wall. ex Nees: A Review of Ethnobotany, Phytochemistry, and Pharmacology
2014 Standout
Critical nodes in signalling pathways: insights into insulin action
2006 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Choice of initial therapy for hypertension
1996
The Metabolic Syndrome: Time for a Critical Appraisal
2005 Standout
American College of Endocrinology Position Statement on the Insulin Resistance Syndrome
2003
Repaglinide Versus Nateglinide Monotherapy
2004
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
1999 Standout
A comprehensive definition for metabolic syndrome
2009 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of Cynthia Clinkingbeard being referenced
Women's Knowledge about Menopause, Hormone Replacement Therapy (HRT), and Interactions with Healthcare Providers: An Exploratory Study
1999
Changes in Glucose, Insulin, Lipid, Lipoprotein, and Apoprotein Concentrations and Insulin Action in Doxazosin-Treated Patients With Hypertension
1994
The Physiological Role of Atrial Natriuretic Hormone in the Regulation of Aldosterone and Salt and Water Metabolism*
1990
Insulin Resistance, Hyperinsulinemia, and Dyslipidemia in Nonobese Individuals With a Family History of Hypertension
1992
Comparison of the hemodynamic and metabolic effects of low-dose hydrochlorothiazide and lisinopril treatment in obese patients with high blood pressure
1995
Additive effects of obesity, hypertension, and type 2 diabetes on insulin resistance.
1994
Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.
2000